| Full Name | Aiden Redmond |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 10 West St, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669145066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 081205-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aiden Redmond, 10 West St, Concord, NH 03301-3548 Ph: (603) 225-0123 | Aiden Redmond, 10 West St, Concord, NH 03301-3548 Ph: (603) 225-0123 |
News Archive
Among patients with obstructive sleep apnea and hypertension that requires 3 or more medications to control, continuous positive airway pressure treatment for 12 weeks resulted in a decrease in 24-hour average and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern, compared to patients who did not receive CPAP, according to a study appearing in the December 11issue of JAMA.
The U.S. Food and Drug Administration (FDA) has announced that New Era Canning Company, New Era, Mich., is expanding its product recall because of potential Clostridium botulinum (C. botulinum) contamination to all canned green beans and garbanzo beans distributed by the company nationwide over the last five years.
Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.
Cancer cells circulating in the blood, or circulating tumour cells (CTCs), are known to be associated with a bad prognosis in women with metastatic breast cancer. Now, for the first time, a group of scientists have shown that they can also detect CTCs before and after chemotherapy treatment and hence may be able to identify those patients likely to have a recurrence of their cancer after such treatment in future.
› Verified 5 days ago
Sandra L Bell, ARNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-6108 | |
Elizabeth Vreeland, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Pleasant St, Concord, NH 03301 Phone: 603-226-7547 | |
Linda Lapierre, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 West St, Concord, NH 03301 Phone: 603-225-0123 | |
Rachel Buchanan, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 | |
Daryl Boire, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 | |
Christine Jensik, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 40 Pleasant St, Concord, NH 03301 Phone: 603-225-0123 | |
Geraldine Chase, RNC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 278 Pleasant St, Concord, NH 03301 Phone: 603-228-1600 |